期刊文献+

线粒体功能异常与亨廷顿舞蹈病的病理发生机制 被引量:2

Role of Mitochondrial Dysfunction in Huntington's Disease
下载PDF
导出
摘要 亨廷顿舞蹈病(Huntington’s disease,HD)是一种致命的遗传性神经退行性疾病,它是由亨廷顿蛋白N-端的多聚谷氨酰胺延长造成的。该病表现为纹状体中的中型棘神经元(medium spiny neurons,MSN)逐渐丢失。HD的致病机理还不完全清楚,目前越来越多的研究结果显示线粒体在HD中发挥着重要作用。已有证据充分表明了HD细胞中线粒体的形态和结构发生了明显改变。此外,HD细胞中线粒体某些电子传递链复合物蛋白活性或蛋白表达水平的降低,以及突变亨廷顿蛋白对细胞核基因转录的影响进一步引起了线粒体功能障碍。除了线粒体形态和功能的改变,HD细胞线粒体的Ca2+稳态也发生了紊乱,且线粒体的氧化压力水平显著升高,进而导致HD细胞线粒体基因组DNA损伤。由于线粒体在细胞凋亡过程发挥着重要作用,因此HD细胞中线粒体的这些变化揭示了线粒体异常参与了HD细胞特别是HD神经细胞的凋亡过程。本综述将集中探讨HD中线粒体的一系列异常变化,为阐明HD的发病机理和HD治疗提供一些启发。 Huntington’s disease (HD) is a fatal inherited neurodegenerative disorder with the progressive loss of striatal medium spiny neurons (MSN), caused by a polyglutamine expansion in the N-terminus of huntingtin protein. Pathogenic mechanism of HD is not fully understood, but increasing evidences indicate that dysfunction of mitochondria plays an important role in HD pathogenesis. The morphology and structure of mitochondria in HD are changed due to a series of pathogenic factors. Moreover, the activity and/or expression levels of some mitochondrial electron transport chain protein complexes are decreased, and the mitochondrial biogenesis is impaired by mutant huntingtin protein. Furthermore, dysregulation of mitochondrial Ca2+ homeostasis and excessive mitochondrial oxidant generation have been recently demonstrated in HD cells/neurons.All of these changes in HD mitochondria could cause the dysfunction of mitochondria, which in turn lead to cell death in HD cells, especially in neuron. This review will focus on the role of mitochondrial dysfunction in the pathogenesis of HD and the therapeutic strategy targeted on mitochondria for the treatment of HD.
出处 《神经药理学报》 2012年第4期47-57,共11页 Acta Neuropharmacologica
基金 科技部重大科学计划项目(No.2011CB965003 No.2011CB944302 No.2012CB944702) 国家自然科学基金项目(No.30970588 No.31170730 No.81371415) 中科院百人计划项目
关键词 亨廷顿舞蹈病 线粒体 细胞凋亡 活性氧 Huntington’s disease mitochondria apoptosis reactive oxygen species
  • 相关文献

参考文献99

  • 1Vonsattel G,Jean Paul, Difiglia Marian. Huntington disease [J]. J Neuropathol Experl Neurol, 1998,57(5) : 369-384.
  • 2Schwarcz Robert,Whetsell William O, Mangano Richard M. Quinolinic acid:an endogenous metabolite that produces axon-sparing lesions in rat brain [J]. Science, 1983,219(4582):316-318.
  • 3M Flint Beal,Emmanuel Brouillet, Bruce G Jenkins,et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid [J]. J Neurosci, 1993,13(10):4181- 4192.
  • 4Damiano Maria,Galvan Laurie,Deglon Nicole,et al Mitochondria in Huntington's disease [J]. Biochim Biophys Acta,2010,1802(1):52-61.
  • 5Mangiarini Laura,Sathasivam Kirupa, Seller Mary,et al Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice [J]. Cell, 1996,87(3) :493-506.
  • 6Levine Michael S,Klapstein Gloria J,Koppel Ahrin,et al. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease [J]. J Neurosci Res, 1999,58(4) : 515- 532.
  • 7Turmaine Mark, Raza Aysha, Mahal Amarbirpal, et al Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease [J]. Proceed National Acad Sci, 2000,97(14) : 8093-8097.
  • 8Davies Stephen W, Turmaine Mark, Cozens Barbara A, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J]. Cell, 1997,90(3) : 537-548.
  • 9Hodgson J Graeme,Agopyan Nadia, Gutekunst Claire- Anne,et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin,cyt and selective striatal neurodegeneration oplasmic toxicity, [J]. Neuron, 1999, 23(1): 181-192.
  • 10Slow Elizabeth J, Van Raamsdonk Jeremy,Rogers Daniel, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease [J]. Hum Mol Genet,2003, 12(13):1555-1567.

同被引文献48

  • 1Cheng-yun JIN,Jae-dong LEE,Cheol PARK,Yung hyun CHOI,Gi-young KIM.Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia[J].Acta Pharmacologica Sinica,2007,28(10):1645-1651. 被引量:10
  • 2Castellani R J,Rolston R K,Smith M A.Alzheimer disease.Dis Mon,2010,56(9):484-546.
  • 3Parkinson's disease information.Parkinson's disease diagnosis. ( 2009-6- 23 )[2010-10-15 ].hap://www.parkinsons.org/.
  • 4Huntington's Disease Assoeiation.HD:What is Huntington's disease?.[2010-10-15].http://www.hda.org.uk/.
  • 5Link C D,Taft A,Kapulkin V,et al.Gene expression analysis in a transgenic C. elegans Alzheimer's disease model.Neurobiol Aging,2003,24(3):397-413.
  • 6Link C D.C.elegans models of age-associated neurodegenerative diseases:lessons from transgenic worm models of Alzheimer's disease.ExP Gerontol,2006,41 ( 10): 1007 - 1013.
  • 7Boyd-K!mball D,Poon H F,Lvnn B C,et al.Proteomic identification of proteins specifically oxidized in C. elegans expressing human Abeta(1-42):implication for Alzheimer's disease.Neurobiol Aging,2006,27(9): 1239-1249.
  • 8WU Y,WU Z,Butko P,et al.Amyloid-beta-indueed pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and gink-golides in transgerric Caenorhabditis elegans.J Neuroseience, 2006,26(50):13102-13113.
  • 9Van Raamsdonk J M,Hekimi S.Reactive Oxygen Species and Aging in Caenorhabditis elegans:Causal or Casual Relationship Antioxidants&Tedox Signaling,2010,13(12):1911-53.
  • 10Hikishima K,Ando K,Komaki K,et al.Voxel-based morphometry of the marmoset brain:In vivo detection of volume loss in the substantia nigra of the MPTP-treated Parkinson's disease model. Neuroscience,2015,5( 1):585-592.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部